AI-assisted Decision-making of Reoperation for Postoperative Bleeding of Gastric Cancer

Recruiting Observational Study
Gastrectomy for Gastric Cancer Gastric Cancer
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 90
Sex
Any
Study type
Observational
Participants needed
7,000 (estimated)
Sponsor
First Affiliated Hospital of Zhejiang University · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
The goal of this observational study is to develop and validate a deep learning model to dynamically assess postoperative bleeding risk and assist in decision-making for re-operation in adult patients (≥18 years) diagnosed with primary gastric cancer undergoing radical gastrectomy. The main question\[s\] it aims to answer \[is/are\]: Can an AI model based on perioperative dynamic physiological pa…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: 1. Age: Patients aged ≥ 18 years. 2. Diagnosis: Histologically confirmed primary gastric cancer. 3. Surgical Procedure: Underwent radical gastrectomy (including proximal, distal, or total gastrectomy). 4. Consent: Provision of written informed consent (required specifically for …
Contacts

Jianghao Li, B.S. in Computer Science

86+15968774033

12518934@zju.edu.cn

CONTACT